Karolinska University Hospital
Stockholm, Sweden
NCT Number: NCT03140917
In liver surgery peroperative assessment och the future liver remnant (FLR) is pivotal in order to avoid posthepatectomy liver failure. To date this is mainly performed by measuring the volume of the FLR. Of course FLR volume acts as a surrogate measure of FLR function and the correlation between volume and function is not always accurate. Several techniques to assess FLR function has been proposed. Hepatobiliary scintigraphy (HBS) and Dynamic MRI are the two such methods. In this study we compare HBS and MRI, in addition to contrast-enhanced CT and ICG, repeatedly performed before and after right hepatectomy in patients with colorectal liver metastases treated with neoadjuvant chemotherapy.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Stockholm, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
HBS, MRI, CE-CT and ICG
Time frame: Preop
HBS, MRI, CT and ICG performed the day before surgery
Time frame: POD 7
HBS, MRI, CT and ICG performed 7 days after surgery
Time frame: POD 28
HBS, MRI, CT and ICG performed 28 days after surgery
Karolinska University Hospital
Other
Multimodal Assessment of Liver Volume and Function in Patients With Colorectal Liver Metastases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00208260
Chemotherapy, Colonic Diseases
Montpellier, France
View Trial DetailsNCT03366155
Colonic Diseases, Colorectal Adenocarcinoma
Bethesda, Maryland, United States
View Trial DetailsNCT02162563
Colonic Diseases, Colorectal Cancer
Antwerp, Belgium
View Trial DetailsNCT06404593
Circulating Tumor DNA, Colonic Diseases
Beijing, Beijing Municipality, China
View Trial Details